Effect of microrna-138 on epithelial-Mesenchymal transition and invasion of breast cancer cells by targeting semaphorin 4C

被引:7
作者
Liu, HuiJuan [1 ]
Ye, Hui [2 ]
Li, Xinzheng [1 ]
机构
[1] Shanxi Canc Hosp, Ward Breast Surg 2, Taiyuan 030009, Peoples R China
[2] Shanxi Canc Hosp, Ward Thorac Surg 3, Taiyuan, Peoples R China
关键词
Breast cancer; miR-138; semaphorin; 4C; epithelial mesenchymal transition; invasion; PROMOTES; PROLIFERATION; SEMA4C;
D O I
10.1080/21655979.2021.2000733
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In view of the role of miR-138 in cancer cells, we predicted the target of miR-138 and its targeting to SEMA4C by bioinformatics software and luciferase experiment. The expression levels of miR-138 in human normal breast epithelial cells and two kinds of BC cells were compared, and the transfection cells were selected. MiR-138 mimetic negative control (miR-NC), miR-138 mimic and miR-138 inhibitor were designed for cell transfection. The results showed that the expression level of miR-138 in MCF-7 cells was the lowest. The up regulation of miR-138 would lead to the high expression of E-cad and the low expression of N-cad, vim and SEMA4C, and the vitality and invasion of BC cells would decrease. The down regulation of miR-138 would lead to the low expression of E-cad and the high expression of N-cad, vim and SEMA4C, and the vitality and invasion of BC cells would increase. miR-138 targeted regulation of SEMA4C can promote the expression of N-cad, inhibit the expression of E-cad, vim and SEMA4C, reverse the EMT of BC cells, and inhibit the activity and invasion of BC cells. MiR-138 has clinical potential as a tumor marker of BC.
引用
收藏
页码:10117 / 10125
页数:9
相关论文
共 50 条
[21]   Epithelial-mesenchymal transition as a potential route for DAPT resistance in breast cancer cells [J].
Telli, Kubra ;
Yalcin-Ozuysal, Ozden .
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2023, 48 (01) :88-95
[22]   MicroRNA control of epithelial-mesenchymal transition in cancer stem cells [J].
Hao, Jin ;
Zhang, Yueling ;
Deng, Mengzhao ;
Ye, Rui ;
Zhao, Sen ;
Wang, Yating ;
Li, Juan ;
Zhao, Zhihe .
INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (05) :1019-1027
[23]   Neuromedin B receptor antagonism inhibits migration, invasion, and epithelial-mesenchymal transition of breast cancer cells [J].
Park, Hyun-Joo ;
Kim, Mi-Kyoung ;
Choi, Kyu-Sil ;
Jeong, Joo-Won ;
Bae, Soo-Kyung ;
Kim, Hyung Joon ;
Bae, Moon-Kyoung .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 49 (03) :934-942
[24]   MicroRNA-92b inhibits epithelial-mesenchymal transition-induced migration and invasion by targeting Smad3 in nasopharyngeal cancer [J].
Zhao, Chong ;
Zhao, Feipeng ;
Feng, Huajun ;
Xu, Shengen ;
Qin, Gang .
ONCOTARGET, 2017, 8 (53) :91603-91613
[25]   Epithelial-Mesenchymal Transition and Breast Cancer [J].
Wu, Yanyuan ;
Sarkissyan, Marianna ;
Vadgama, Jaydutt V. .
JOURNAL OF CLINICAL MEDICINE, 2016, 5 (02)
[26]   Role of fucosyltransferase IV in epithelial-mesenchymal transition in breast cancer cells [J].
Yang, X. ;
Liu, S. ;
Yan, Q. .
CELL DEATH & DISEASE, 2013, 4 :e735-e735
[27]   Adipocytes can induce epithelial-mesenchymal transition in breast cancer cells [J].
Lee, YuKyung ;
Jung, Woo Hee ;
Koo, Ja Seung .
BREAST CANCER RESEARCH AND TREATMENT, 2015, 153 (02) :323-335
[28]   Adipocytes can induce epithelial-mesenchymal transition in breast cancer cells [J].
YuKyung Lee ;
Woo Hee Jung ;
Ja Seung Koo .
Breast Cancer Research and Treatment, 2015, 153 :323-335
[29]   PADI4-mediated epithelial-mesenchymal transition in lung cancer cells [J].
Liu, Meiyan ;
Qu, Yang ;
Teng, Xue ;
Xing, Ying ;
Li, Dandan ;
Li, Chunhong ;
Cai, Li .
MOLECULAR MEDICINE REPORTS, 2019, 19 (04) :3087-3094
[30]   MicroRNA-302c represses epithelial-mesenchymal transition and metastasis by targeting transcription factor AP-4 in colorectal cancer [J].
Ma, Wenqi ;
Liu, Bailing ;
Li, Jie ;
Jiang, Jue ;
Zhou, Ru ;
Huang, Lili ;
Li, Xiaopeng ;
He, Xin ;
Zhou, Qi .
BIOMEDICINE & PHARMACOTHERAPY, 2018, 105 :670-676